crotedumab crotedumab crotedumab (regn1193) (inn) is a humanized monoclonal antibody designed for the treatment of diabetes. crotedumabmonoclonal antibodytypewhole antibodysourcehumantargetgcgrclinical dataother namesregn1193atc codenoneidentifierscas number1452387-69-7chemspidernoneunii4jq68pw6xfkeggd11230chemical and physical dataformulac6518h10044n1732o2052s46molar mass146976.88 g·mol−1 this drug was developed by regeneron pharmaceuticals.